Temporary Suspension

Summary by AI BETAClose X

Octagon Healthcare Funding PLC has announced a short delay in publishing its audited financial statements for the year ended 31 December 2025 due to the auditor requiring additional time for technical procedures related to specific accounting treatments. Consequently, the listing of the company's £341,328,000 5.333 per cent. Guaranteed Secured Bonds due 2035 has been suspended until the financial statements are finalized and published. The company currently holds operating cash of £30,042,481 and £30,249,380 in contractually reserved funds, and no Event of Default or Acceleration Event is outstanding.

Disclaimer*

Octagon Healthcare Funding PLC
01 May 2026
 

Delay to publication of audited accounts

Octagon Healthcare Funding PLC

1 May 2026

DISCLAIMER

Please note that the information contained in this notice may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus dated 11 December 2003 relating to the issue by Octagon Healthcare Funding PLC of £341,328,000 5.333 per cent. Guaranteed Secured Bonds due 2035 (the Prospectus)) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed.  Prior to relying on the information contained in this notice you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained herein.

Your right to access this service is conditional upon complying with the above requirement.

This information in this notice is not intended to be a complete and up to date description of all of the activities and risks within the Octagon Group (as defined below). Nothing in this notice constitutes an offer to sell or the solicitation of an offer to buy any Bonds or any other securities of the Issuer or any other person.

Octagon Healthcare Funding PLC - £341,328,000 5.333 per cent. Guaranteed Secured Bonds due 2035

Introduction

On 11 December 2003, Octagon Healthcare Funding PLC (the Issuer) issued £341,328,000 5.333 per cent. Guaranteed Secured Bonds due 2035 (the Bonds) and on-lent the proceeds of the Bonds to Octagon Healthcare Limited (ProjectCo) pursuant to an on-loan agreement dated 11 December 2003 (as amended or supplemented from time to time). In connection with the Bonds, the Issuer and ProjectCo also entered into a collateral deed with, amongst others, HSBC Trustee (C.I.) Limited (the Bond Trustee) (the Collateral Deed).

ProjectCo and Issuer, together with ProjectCo's immediate holding company Octagon Healthcare (Norwich) Holdings Limited (the HoldCo), form the Octagon Healthcare (Norwich) group of companies (Octagon Group).

Delay to publication of Octagon Group's audited financial statements

The Issuer announces that there will be a short delay in publishing the Octagon Group's consolidated audited financial statements for the financial year ended 31 December 2025 (the 2025 Financial Statements) in accordance with the requirements of the FCA's Disclosure Guidance and Transparency Rules sourcebook.

Despite the best efforts of all parties, the Octagon Group requires further time for the auditor to complete limited and technical procedures in respect of the 2025 Financial Statements audit.

These relate to an extended review of specific accounting treatments used in the 2025 Financial Statements.

The FCA has been made aware of the delay to the publication of the 2025 Financial Statements and the listing of the Bonds has been suspended until the 2025 Financial Statements have been finalised and published in accordance with the FCA's Disclosure Guidance and Transparency Rules sourcebook.  Upon publication of the 2025 Financial Statements, the Issuer intends to promptly apply for the listing to be reinstated.

The Issuer is continuing to work with the auditor to ensure that the audit of the 2025 Financial Statements can be completed as soon as possible to enable the listing of the Bonds to be reinstated promptly.  The Issuer therefore remains compliant with the terms of the Bonds and the Collateral Deed and no Event of Default or Acceleration Event is outstanding thereunder.

The Issuer has provided details to the Bond Trustee and the Credit Provider as to the delay and will continue to keep them appraised of any further developments.

Current trading

ProjectCo presently holds operating cash of £30,042,481 in addition to £30,249,380 of contractually reserved funds. 

For further information or to arrange a meeting with Octagon Healthcare Funding PLC's management, please contact:

 

 

Andrew Sacher (Manager's representative)

0203 405 1305

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings